CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• New Robot-Compatible Sterile Connectors Enhance Cell Therapy Manufacturing

  Discover how automating sterile fluid transfers removes human contamination risks, solves operator shortages, and reduces cell therapy manufacturing costs by up to 74%.

• Expansion Of Human Bone Marrow-Derived MSCs

  Achieving over 870 million viable, quality mesenchymal stem/stromal cells is possible. This efficient cell culture method scales bone marrow-derived MSCs for clinical needs.

• Enhance Access And Improve Retention In Rare Disease Trials With HTS

  Home Trial Support (HTS) provides a solution to improving participant recruitment and retention during musculoskeletal studies.

• Digital Biomanufacturing, Now: From Digital Dreamer To Digital Doer

  Discover how digital biomanufacturing is revolutionizing drug production by exploring strategies for integrating digital technologies to enhance efficiency and innovation in bioprocessing workflows.

• Optimizing EDC Strategy And Data Collection for a Rare Disease Trial

  Explore how Veristat created a forward-looking roadmap for EDC and CRFs integration for a small biotech sponsor, ensuring a future-ready data ecosystem without overcomplicating current operations.

• Scalability From 5L To 50L Using The DynaDrive Single-Use Bioreactor

  Maintaining a consistent bioprocess when scaling from 5 L to 50 L is achievable. This study shows how to successfully scale processes while maintaining cell density, viability, and protein production.

• Partnering With Health Systems: Essential Tips For CGT Commercialization

  Successful cell and gene therapy commercialization requires early, detailed manufacturer collaboration with health systems to ensure scalable operations and seamless patient access beyond the clinical trial.

• Smart Scale-Up: Expanding Viral Vectors With Microcarrier Bead Technology

  Scale up your manufacturing of adherent cell cultures used for viral vector-based treatments with the novel technologies needed to facilitate safe, rapid production.

• A Sterilizing-Grade Membrane For Efficient Filtration Of Biologics

  Higher flow rates and a smaller process footprint can create meaningful gains across sterile filtration steps. Explore the performance data and where efficiency improvements may be possible.

• Targeted Indication Selection Using Adaptive Design

  What is a Simon 2-stage design, and how was it used to enable each tumor-specific cohort in a Phase 2, multi-cohort oncology trial to be independently assessed for objective response rates?